查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1813919

美國非處方連續血糖監測 (OTC) 設備市場規模、佔有率和趨勢分析報告：按用戶、應用、銷售管道和細分市場預測，2025 年至 2033 年

U.S. OTC Continuous Glucose Monitoring Devices Market Size, Share & Trends Analysis Report By Users (Non-Diabetic, Prediabetic, Diabetic), By Application (Lifestyle Wellness, Diabetes Monitoring), By Sales Channel, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 125 Pages | 商品交期: 2-10個工作天內

價格

市場規模與趨勢：

美國OTC 連續血糖監測 (CGM) 設備市場預計在 2024 年達到 4,861 萬美元，到 2033 年將達到 9,352 萬美元，2025 年至 2033 年的複合年成長率為 8.0%。

生活健康設備的日益普及，包括用於更便捷糖尿病管理的連續血糖監測 (CGM)，以及穿戴式健康工具的便利使用，正在推動需求成長。例如，到 2024 年，超過 44% 的美國成年人將使用穿戴式健康工具進行疾病監測和管理。

此外，預計未來5到10年，美國老年族群的採用率將達到50%。日益成長的老年人口和久坐不動的生活方式加劇了疾病負擔，因此迫切需要開發像CGM這樣的先進監測解決方案。此外，醫療保健基礎設施的不斷擴大以及透過非處方箋電商管道分銷CGM設備，將促進人們獲取這些設備。感測器精度、應用程式整合和數據共用等技術進步將進一步推動都市區和半都市區的市場成長。

截至2025年，美國將有約3,800萬成年人被診斷出患有糖尿病，占美國成年人口總數的11.5%。此外，美國約有9700萬成年人處於糖尿病前期。肥胖和久坐不動的生活方式是導致糖尿病流行的主要因素。 2型糖尿病患者數量的持續激增以及人們對早期診斷意識的不斷提高，可能會推動美國對非處方動態血糖監測（OTC CGM）設備的需求。

新推出的非處方 (OTC) 動態血糖監測 (CGM) 設備提案用於未使用胰島素的第 2 型糖尿病患者。由於處方箋CGM 不在第 2 型糖尿病保險範圍內，因此 OTC 設備可以提供協助。 OTC CGM 價格實惠，無需處方箋即可購買。雖然 OTC CGM 不在保險範圍內，但 HAS/FSA 基金通常可以接受。

目錄

第1章調查方法與範圍

第2章執行摘要

第 3 章美國OTC 連續血糖監測 (CGM) 設備市場變數、趨勢與範圍

  • 市場介紹/電網展望
  • 市場規模和成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 美國OTC CGM設備市場分析工具
    • 波特分析
    • PESTEL分析

第4章美國OTC連續血糖監測（CGM）設備市場用戶估計與趨勢分析

  • 細分儀表板
  • 美國OTC CGM設備市場用戶波動
  • 2024 年至 2033 年美國OTC CGM 設備市場規模及使用者趨勢分析
  • 非糖尿病患者
  • 糖尿病前期
  • 糖尿病患者

第5章美國OTC連續血糖監測（CGM）設備市場應用預測與趨勢分析

  • 細分儀表板
  • 美國OTC CGM設備市場應用波動
  • 2024-2033 年美國OTC CGM 設備市場規模及應用趨勢分析
  • 生活方式健康
  • 糖尿病監測

第6章美國OTC連續血糖監測（CGM）設備市場依銷售管道的估計與趨勢分析

  • 細分儀表板
  • 美國OTC CGM設備市場按銷售管道的波動
  • 美國OTC CGM 設備市場規模與銷售管道趨勢分析（2025-2033 年）
  • 公司網站
  • 零售商

第7章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司分類
  • 公司熱圖分析
  • 公司簡介
    • Abbott Laboratories
    • Dexcom Inc.
Product Code: GVR-4-68040-717-8

Market Size & Trends:

The U.S. OTC continuous glucose monitoring devices market size was estimated at USD 48.61 million in 2024 and is expected to reach USD 93.52 million by 2033, growing at a CAGR of 8.0% from 2025 to 2033. The rising adoption of lifestyle wellness devices, including continuous glucose monitoring (CGM) to ease diabetes management, and the easy access to wearable health tools are fueling demand. For instance, in 2024, more than 44% of American adults adopted wearable health tools for disease monitoring and management.

Additionally, in the coming 5 to 10 years, the adoption rate is expected to reach 50% among elderly Americans. The growing geriatric population and sedentary lifestyles contribute to the disease burden, imposing the development of advanced monitoring solutions such as CGM. Furthermore, expanding healthcare infrastructure and distribution of CGM devices through e-commerce without a prescription would ease accessibility. Technological advancements like sensor accuracy, app integration, and data sharing further support market growth across urban and semi-urban areas.

As of 2025, nearly 38 million American adults are diagnosed with diabetes, marking 11.5% of the total adult population in the U.S. Furthermore, around 97 million adults are prediabetic in the country. Obesity and a sedentary lifestyle are the major contributing factors to the prevalence of diabetes. Continued surge in type 2 diabetes cases and growing awareness of early diagnoses are likely to boost the demand for OTC CGM devices in the U.S.

Newly introduced OTC CGM devices are suggested to be used by type 2 diabetes that are not on insulin. As type 2 diabetes does not get the insurance for prescription CGM, OTC comes in as a help. OTC CGM sells at an affordable rate and without a prescription. Although the OTC CGMs are not covered by insurance, the HAS/FSA funds are generally accepted.

U.S. OTC Continuous Glucose Monitoring Devices Market Report Segmentation

This report forecasts revenue growth at country levels and analyzes the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. OTC continuous glucose monitoring devices market report based on user, application, and sales channel:

  • User Outlook (Revenue, USD Million, 2021 - 2033)
    • Non-diabetic
    • Prediabetic
    • Diabetic
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
    • Lifestyle Wellness
    • Diabetes Monitoring
  • Sales Channel Outlook (Revenue, USD Million, 2021 - 2033)
    • Company Website
    • Retailers

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. OTC CGM Devices Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. U.S. OTC CGM Devices Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. U.S. OTC CGM Devices Market: User Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. OTC Continuous Glucose Monitoring (CGM) Devices Market User Movement Analysis
  • 4.3. U.S. OTC Continuous Glucose Monitoring (CGM) Devices Market Size & Trend Analysis, by User, 2024 to 2033 (USD Million)
  • 4.4. Non-diabetic
    • 4.4.1. Non-diabetic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Prediabetic
    • 4.5.1. Prediabetic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Diabetic
    • 4.6.1. Diabetic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. OTC CGM Devices Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. OTC Continuous Glucose Monitoring (CGM) Devices Market Application Movement Analysis
  • 5.3. U.S. OTC Continuous Glucose Monitoring (CGM) Devices Market Size & Trend Analysis, by Application, 2024 to 2033 (USD Million)
  • 5.4. Lifestyle Wellness
    • 5.4.1. Lifestyle wellness market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. Diabetes Monitoring
    • 5.5.1. Diabetes monitoring market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. OTC CGM Devices Market: Sales Channel Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. OTC Continuous Glucose Monitoring Devices Market Sales Channel Movement Analysis
  • 6.3. U.S. OTC Continuous Glucose Monitoring Devices Market Size & Trend Analysis, by Sales Channel, 2025 to 2033 (USD Million)
  • 6.4. Company Website
    • 6.4.1. Company website Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Retailers
    • 6.5.1. Retailers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Abbott Laboratories
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Dexcom Inc.
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. OTC continuous glucose monitoring devices by user, 2021 - 2033 (USD Million)
  • Table 4 U.S. OTC continuous glucose monitoring devices by application, 2021 - 2033 (USD Million)
  • Table 5 U.S. OTC continuous glucose monitoring devices by sales channel, 2021 - 2033 (USD Million)
  • Table 6 Participant's overview
  • Table 7 Financial performance
  • Table 8 Key companies undergoing expansions
  • Table 09 Key companies undergoing acquisitions
  • Table 10 Key companies undergoing collaborations
  • Table 11 Key companies launching new products
  • Table 12 Key companies undergoing partnerships
  • Table 13 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 U.S. OTC CGM devices market segmentation
  • Fig. 7 Market driver analysis (Current & future impact)
  • Fig. 8 Market restraint analysis (Current & future impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 U.S. OTC continuous glucose monitoring devices user outlook key takeaways (USD Million)
  • Fig. 12 U.S. OTC continuous glucose monitoring devices market user movement analysis 2024 & 2033 (USD Million)
  • Fig. 13 Non-diabetic market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Prediabetes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Diabetes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 U.S. OTC continuous glucose monitoring devices application outlook key takeaways (USD Million)
  • Fig. 17 U.S. OTC continuous glucose monitoring devices market application movement analysis 2024 & 2033 (USD Million)
  • Fig. 18 Lifestyle wellness market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Diabetes monitoring market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 U.S. OTC continuous glucose monitoring devices sales channel outlook key takeaways (USD Million)
  • Fig. 21 U.S. OTC continuous glucose monitoring devices sales channel analysis 2024 & 2033 (USD Million)
  • Fig. 22 Company website market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Retailers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Heat map analysis
  • Fig. 25 Market participant categorization
  • Fig. 26 U.S. OTC continuous glucose monitoring devices market share analysis, 2024
  • Fig. 27 Strategy framework